A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

Scott C. Smith; Aleksandra V. Petrova; Matthew Z. Madden; Hongyan Wang; Yunfeng Pan; Matthew D. Warren; Claire W. Hardy; Dong Liang; Elaine A. Liu; M. Hope Robinson; Soumon Rudra; Jie Wang; Shahrzad Ehdaivand; Mylin A. Torres; Ya Wang; David S. Yu

doi:10.1093/nar/gku840

A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

Scott C. Smith, Aleksandra V. Petrova, Matthew Z. Madden, Hongyan Wang, Yunfeng Pan, Matthew D. Warren, Claire W. Hardy, Dong Liang, Elaine A. Liu, M. Hope Robinson, Soumon Rudra, Jie Wang, Shahrzad Ehdaivand, Mylin A. Torres, Ya Wang, David S. Yu

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Abstract

The Replication Stress Response (RSR) is a signaling network that recognizes challenges to DNA replication and coordinates diverse DNA repair and cell-cycle checkpoint pathways. Gemcitabine is a nucleoside analogue that causes cytotoxicity by inducing DNA replication blocks. Using a synthetic lethal screen of a RNAi library of nuclear enzymes to identify genes that when silenced cause gemcitabine sensitization or resistance in human triple-negative breast cancer cells, we identified NIMA (never in mitosis gene A)-related kinase 9 (NEK9) as a key component of the RSR. NEK9 depletion in cells leads to replication stress hypersensitivity, spontaneous accumulation of DNA damage and RPA70 foci, and an impairment in recovery from replication arrest. NEK9 protein levels also increase in response to replication stress. NEK9 complexes with CHK1, and moreover, NEK9 depletion impairs CHK1 autophosphorylation and kinase activity in response to replication stress. Thus, NEK9 is a critical component of the RSR that promotes CHK1 activity, maintaining genome integrity following challenges to DNA replication.

Original language	English (US)
Pages (from-to)	11517-11527
Number of pages	11
Journal	Nucleic acids research
Volume	42
Issue number	18
DOIs	https://doi.org/10.1093/nar/gku840
State	Published - Oct 13 2014
Externally published	Yes

ASJC Scopus subject areas

Genetics

Access to Document

10.1093/nar/gku840

Cite this

Smith, S. C., Petrova, A. V., Madden, M. Z., Wang, H., Pan, Y., Warren, M. D., Hardy, C. W., Liang, D., Liu, E. A., Robinson, M. H., Rudra, S., Wang, J., Ehdaivand, S., Torres, M. A., Wang, Y., & Yu, D. S. (2014). A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response. Nucleic acids research, 42(18), 11517-11527. https://doi.org/10.1093/nar/gku840

@article{2c4bc4a3ed1741eea95686f057d9cae5,

title = "A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response",

abstract = "The Replication Stress Response (RSR) is a signaling network that recognizes challenges to DNA replication and coordinates diverse DNA repair and cell-cycle checkpoint pathways. Gemcitabine is a nucleoside analogue that causes cytotoxicity by inducing DNA replication blocks. Using a synthetic lethal screen of a RNAi library of nuclear enzymes to identify genes that when silenced cause gemcitabine sensitization or resistance in human triple-negative breast cancer cells, we identified NIMA (never in mitosis gene A)-related kinase 9 (NEK9) as a key component of the RSR. NEK9 depletion in cells leads to replication stress hypersensitivity, spontaneous accumulation of DNA damage and RPA70 foci, and an impairment in recovery from replication arrest. NEK9 protein levels also increase in response to replication stress. NEK9 complexes with CHK1, and moreover, NEK9 depletion impairs CHK1 autophosphorylation and kinase activity in response to replication stress. Thus, NEK9 is a critical component of the RSR that promotes CHK1 activity, maintaining genome integrity following challenges to DNA replication.",

author = "Smith, {Scott C.} and Petrova, {Aleksandra V.} and Madden, {Matthew Z.} and Hongyan Wang and Yunfeng Pan and Warren, {Matthew D.} and Hardy, {Claire W.} and Dong Liang and Liu, {Elaine A.} and Robinson, {M. Hope} and Soumon Rudra and Jie Wang and Shahrzad Ehdaivand and Torres, {Mylin A.} and Ya Wang and Yu, {David S.}",

note = "Publisher Copyright: {\textcopyright} 2014 The Author(s).",

year = "2014",

month = oct,

day = "13",

doi = "10.1093/nar/gku840",

language = "English (US)",

volume = "42",

pages = "11517--11527",

journal = "Nucleic acids research",

issn = "0305-1048",

publisher = "Oxford University Press",

number = "18",

}

TY - JOUR

T1 - A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

AU - Smith, Scott C.

AU - Petrova, Aleksandra V.

AU - Madden, Matthew Z.

AU - Wang, Hongyan

AU - Pan, Yunfeng

AU - Warren, Matthew D.

AU - Hardy, Claire W.

AU - Liang, Dong

AU - Liu, Elaine A.

AU - Robinson, M. Hope

AU - Rudra, Soumon

AU - Wang, Jie

AU - Ehdaivand, Shahrzad

AU - Torres, Mylin A.

AU - Wang, Ya

AU - Yu, David S.

PY - 2014/10/13

Y1 - 2014/10/13

N2 - The Replication Stress Response (RSR) is a signaling network that recognizes challenges to DNA replication and coordinates diverse DNA repair and cell-cycle checkpoint pathways. Gemcitabine is a nucleoside analogue that causes cytotoxicity by inducing DNA replication blocks. Using a synthetic lethal screen of a RNAi library of nuclear enzymes to identify genes that when silenced cause gemcitabine sensitization or resistance in human triple-negative breast cancer cells, we identified NIMA (never in mitosis gene A)-related kinase 9 (NEK9) as a key component of the RSR. NEK9 depletion in cells leads to replication stress hypersensitivity, spontaneous accumulation of DNA damage and RPA70 foci, and an impairment in recovery from replication arrest. NEK9 protein levels also increase in response to replication stress. NEK9 complexes with CHK1, and moreover, NEK9 depletion impairs CHK1 autophosphorylation and kinase activity in response to replication stress. Thus, NEK9 is a critical component of the RSR that promotes CHK1 activity, maintaining genome integrity following challenges to DNA replication.

AB - The Replication Stress Response (RSR) is a signaling network that recognizes challenges to DNA replication and coordinates diverse DNA repair and cell-cycle checkpoint pathways. Gemcitabine is a nucleoside analogue that causes cytotoxicity by inducing DNA replication blocks. Using a synthetic lethal screen of a RNAi library of nuclear enzymes to identify genes that when silenced cause gemcitabine sensitization or resistance in human triple-negative breast cancer cells, we identified NIMA (never in mitosis gene A)-related kinase 9 (NEK9) as a key component of the RSR. NEK9 depletion in cells leads to replication stress hypersensitivity, spontaneous accumulation of DNA damage and RPA70 foci, and an impairment in recovery from replication arrest. NEK9 protein levels also increase in response to replication stress. NEK9 complexes with CHK1, and moreover, NEK9 depletion impairs CHK1 autophosphorylation and kinase activity in response to replication stress. Thus, NEK9 is a critical component of the RSR that promotes CHK1 activity, maintaining genome integrity following challenges to DNA replication.

UR - http://www.scopus.com/inward/record.url?scp=84922347104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922347104&partnerID=8YFLogxK

U2 - 10.1093/nar/gku840

DO - 10.1093/nar/gku840

M3 - Article

C2 - 25217585

AN - SCOPUS:84922347104

SN - 0305-1048

VL - 42

SP - 11517

EP - 11527

JO - Nucleic acids research

JF - Nucleic acids research

IS - 18

ER -

A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this